What you'll learn in this expert session
Meningococcal meningitis is a devastating disease but fortunately vaccination dramatically reduces the risk. And while some meningococcal vaccines are freely available to certain at-risk groups, others need to be paid for by the patient, which can be a barrier. For the treating health professionals, the challenge is to provide patients with the appropriate information and education so they can make a realistic assessment of the cost-benefit equation. This includes making people aware that unfunded does not mean unimportant. A/Prof Richmond will provide practical advice on these important conversations to ensure the best possible outcome.
About the Expert
A/Prof Peter Richmond
A/Prof Peter Richmond is a General Paediatrician and Immunologist at Perth Children’s Hospital and Director of the WA Child and Adolescent Health Research Network. He heads the Vaccine Trials Group, a multidisciplinary research group which provides a coordinated approach to the development, delivery, assessment and promotion of vaccines in our community. His major research interests are in the prevention of meningitis, pneumonia and otitis media and understanding susceptibility to infections in children. He has authored over 200 scientific publications in these areas and has worked in meningococcal vaccine research for over 20 years.
Course curriculum
-
1
How to complete this course
-
Instructions
-
-
2
Meningococcal Conversation Strategies
-
Summary
-
Video lecture (25 mins)
-
Quiz: test your learning (10 mins)
-
-
3
Document your CPD here
-
CPD Documentation and Reflection Activity Tool
-
-
4
Feedback
-
Please let us know your thoughts
-